{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:14:17Z","timestamp":1787498057004,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Arvid Nilssons Foundation"},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30 CA 134274-04"],"award-info":[{"award-number":["P30 CA 134274-04"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.radonc.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T01:56:21Z","timestamp":1458006981000},"page":"76-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-3352","authenticated-orcid":false,"given":"Jacob H.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan R.","family":"Vogelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne C.","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus A.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.03.005_b0005","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1470-2045(10)70072-3","article-title":"Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial","volume":"11","author":"Overgaard","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/02841868709104364","article-title":"Optimal dose distribution for eradication of heterogeneous tumors","volume":"26","author":"Brahme","year":"1987","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(05)01737-7","article-title":"Theragnostic imaging for radiation oncology: dose-painting by numbers","volume":"6","author":"Bentzen","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1470-2045(05)01718-3","article-title":"Dose-painting by numbers: a feasible approach?","volume":"6","author":"Hall","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","article-title":"Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality","volume":"47","author":"Ling","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2006.05.002","article-title":"Dose painting: art or science?","volume":"79","author":"Tanderup","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3109\/0284186X.2014.906747","article-title":"Prescribing and evaluating target dose in dose-painting treatment plans","volume":"53","author":"H\u00e5kansson","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2006.12.070","article-title":"Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer","volume":"68","author":"Madani","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.03.005_b0060","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2010.03.028","article-title":"Adaptive dose painting by numbers for head-and-neck cancer","volume":"80","author":"Duprez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.03.005_b0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2008.05.021","article-title":"Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers","volume":"89","author":"Soto","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semradonc.2010.10.001","article-title":"Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription","volume":"21","author":"Bentzen","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0075","doi-asserted-by":"crossref","first-page":"20140655","DOI":"10.1259\/bjr.20140655","article-title":"Reproducibility of FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET\/CT and PET\/MR","volume":"88","author":"Rasmussen","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2016.03.005_b0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2011.06.020","article-title":"Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer","volume":"101","author":"Madani","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0085","unstructured":"NIH, NCI. <http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf> n.d. <http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf> (accessed February 25, 2015)."},{"key":"10.1016\/j.radonc.2016.03.005_b0090","doi-asserted-by":"crossref","first-page":"081717","DOI":"10.1118\/1.4816308","article-title":"Failure-probability driven dose painting","volume":"40","author":"Vogelius","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2016.03.005_b0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.03.005_b0100","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.03.005_b0105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.03.005_b0110","article-title":"Prognostic value of 18F-Fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma","author":"Rasmussen","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2016.03.005_b0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2009.06.032","article-title":"Reproducibility of \u201cintelligent\u201d contouring of gross tumor volume in non-small-cell lung cancer on PET\/CT images using a standardized visual method","volume":"77","author":"Bayne","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T05:50:34Z","timestamp":1536904234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0167814016001274"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.03.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}